References
- G C J, E C K, H C K, et al Ovarian cancer[J]. Lancet. 2014;384(9951):1376–1388.
- Aminimoghaddam S, Mahmoudzadeh F, Maghsoudnia A. Cervical cancer along with unknown cirrhosis: a misdiagnosed case[J]. J Reprod Infertil. 2015;16(3):174–177.
- T L Y, C S L, K P Y, et al Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis[J]. Am J Physiol Cell Physiol. 2015;309(7):C444–56.
- Annibaldi A, Widmann C. Glucose metabolism in cancer cells[J]. Curr Opin Clin Nutr Metab Care. 2010;13(4):466–470.
- Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?[J]. Nat Rev Cancer. 2016;16(10):635–649.
- R B H, Chandel NS. Targeting glucose metabolism for cancer therapy[J]. J Exp Med. 2012;209(2):211–215.
- Non-Coding EM. RNAs in human disease[J]. Nat Rev Genet. 2011;12(12):861–874.
- R C S, Veronese A, Sabbioni S, et al Non-coding RNAs in the reprogramming of glucose metabolism in cancer[J]. Cancer Lett. 2018;419:167–174.
- Chen B, Li H, Zeng X, et al Roles of microRNA on cancer cell metabolism[J]. J Transl Med. 2012;10(1):228.
- Liu X, Bi L, Wang Q, et al miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer[J]. Oncogene. 2018;37(25):3426–3439.
- Cantuaria G, Fagotti A, Ferrandina G, et al GLUT-1 expression in ovarian carcinoma[J]. Cancer. 2001;92(5):1144–1150.
- K B K, S J R, Tyrer J, et al Identification of six new susceptibility loci for invasive epithelial ovarian cancer[J]. Nat Genet. 2015;47(2):164–171.
- Song H, S J R D, J P T, et al Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population[J]. J Clin Oncol. 2015;33(26):2901–2907.
- M V I, Visone R, Di Leva G, et al MicroRNA signatures in human ovarian cancer[J]. Cancer Res. 2007;67(18):8699–8707.
- Peng X, Cao P, Li J, et al MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo[J]. Cancer Biol Ther. 2015;16(2):261–267.
- Trembling PM, Apostolidou S, Gentry-Maharaj A, et al Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)[J]. BMC Public Health. 2017;17(1):603.
- Ugai T, L E K, Mizuno M, et al Ovarian cancer risk, ALDH 2 polymorphism and alcohol drinking: Asian data from the ovarian cancer association consortium[J]. Cancer Sci. 2018;109(2):435–445.
- Sun Z, Gilbert L, Ciampi A, et al Estimating the prevalence of ovarian cancer symptoms in women aged 50 years or older: problems and possibilities[J]. Am J Epidemiol. 2016;184(9):670–680.
- E E V, Sergushichev A, Griss T, et al Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth[J]. Mol Cell. 2015;60(2):195–207.
- Xiao X, Huang X, Ye F, et al The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer[J]. Sci Rep. 2016;6:21735.
- Gruenewald S, Rennefahrt U, S G M, et al. Metabolic responses in cancer cells with differential susceptibility to GLUT1 inhibition[J]. 2015;75(15):1164.